Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective

被引:5
|
作者
Setyawan, Juliana [1 ]
Fridman, Moshe [2 ]
Hodgkins, Paul [1 ]
Quintero, Javier [3 ]
Erder, M. Haim [1 ]
Katic, Bozena J. [1 ]
Harpin, Valerie [4 ]
机构
[1] Shire, 725 Chesterbrook Blvd, Wayne, PA 19087 USA
[2] AMF Consulting Inc, Los Angeles, CA USA
[3] Hosp Univ Infanta Leonor, Madrid, Spain
[4] Ryegate Childrens Ctr, Sheffield, S Yorkshire, England
关键词
ADHD; Children and adolescents; Treatment outcomes; Treatment satisfaction; Symptom impairment; Comorbidities;
D O I
10.1007/s12402-014-0143-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We evaluated the association between those symptoms/behaviours of attention-deficit/hyperactivity disorder (ADHD) that were present at diagnosis and outcomes of treatment in children and adolescents in six European countries. Physicians abstracted clinical records from patients (6-17 years) diagnosed with ADHD between 2004 and 2007 and treated for >= 2 years. Physicians scored the severity of impairment for core ADHD symptoms and additional (non-core) ADHD symptoms/behaviours at diagnosis and estimated treatment adherence (defined as an estimated >80 % adherence on weekdays and >50 % adherence on weekends). Treatment modalities included pharmacological treatment, behavioural therapy, or both. Pharmacological treatment was further subclassified by medication class. The outcome, optimal treatment success (OTS), was defined as complete symptom control with high satisfaction with treatment. Multivariate logistic regression modelling examined the relationship between OTS and symptom impairment. Of 730 patients, 200 (27 %) achieved OTS. These patients were more likely to demonstrate lower impairment in non-core ADHD symptoms/behaviours and have fewer pre-existing comorbidities. They were also more likely to be adherent and engaged with treatment, with an explicit treatment goal to improve inattention/school performance. Neither core symptoms' severity nor treatment types were associated with OTS. OTS rates were low, with patients having less impairment of non-core ADHD symptoms/behaviours and fewer comorbidities more likely to achieve OTS. Potentially modifiable factors affecting OTS were as follows: treatment adherence, treatment engagement, and a treatment goal to improve inattention/school performance. These data suggest that there may be opportunities to optimize current treatment use, and develop new treatment strategies to improve core and non-core ADHD symptoms/behaviours.
引用
收藏
页码:75 / 87
页数:13
相关论文
共 50 条
  • [31] EFFECT OF LISDEXAMFETAMINE DIMESYLATE ON FUNCTIONAL IMPAIRMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Soutullo, C. A.
    Banaschewski, T.
    Lecendreux, M. L.
    Bloomfield, R.
    Hodgkins, P.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [32] Treatment of attention-deficit hyperactivity disorder by different physician specialties
    Zarin, DA
    Tanielian, TL
    Suarez, AP
    Marcus, SC
    PSYCHIATRIC SERVICES, 1998, 49 (02) : 171 - 171
  • [33] Attention-deficit/hyperactivity disorder in perspective
    Rohde, Luis Augusto
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2010, 19 (10) : 745 - 746
  • [34] Impairment of reading components in children with attention-deficit hyperactivity disorder
    Gonzalez-Perez, P.
    Alberto, D.
    Raquel, M. G.
    Sergio, H. E.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : LXXI - LXXI
  • [35] Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder -: The multimodal treatment study of children with attention-deficit/hyperactivity disorder
    Jensen, PS
    Arnold, LE
    Richters, JE
    Severe, JB
    Vereen, D
    Vitiello, B
    Schiller, E
    Hinshaw, SP
    Elliott, GR
    Conners, CK
    Wells, KC
    March, J
    Swanson, J
    Wigal, T
    Cantwell, DP
    Abikoff, HB
    Hechtman, L
    Greenhill, LL
    Newcorn, JH
    Pelham, WE
    Hoza, B
    Kraemer, HC
    ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (12) : 1088 - 1096
  • [36] Attention-deficit/hyperactivity disorder in perspective
    Luis Augusto Rohde
    European Child & Adolescent Psychiatry, 2010, 19 : 745 - 746
  • [37] An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Olvera, RL
    Pliszka, SR
    Luh, J
    Tatum, R
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1996, 6 (04) : 241 - 250
  • [38] Attention-deficit hyperactivity disorder and suicidality in a treatment naive sample of children and adolescents
    Balazs, Judit
    Miklosi, Monika
    Kereszteny, Agnes
    Dallos, Gyoengyver
    Gadoros, Julia
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 152 : 282 - 287
  • [39] Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder
    Findling, RL
    Short, EJ
    Manos, MJ
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (12): : 1441 - 1447
  • [40] Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders
    Hah, M
    Chang, KK
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) : 996 - 1004